Stockreport

MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals

MeiraGTx Holdings plc - Ordinary Shares  (MGTX) 
PDF LONDON and NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announ [Read more]